Doctor profile · Federal record
Dr. Emily Kennedy, Nurse Practitioner
Family Nurse Practitioner (CMS: Nurse Practitioner) · Staten Island, NY
- NPI 1336761352
- 11 yrs in practice
- Female
- Solo practice
- No sanctions
Practice & contact
- Primary practice
-
16 Elmira Ave
Staten Island, NY 103142311
(917) 584-2103
Credentials & registration
- NPI registered
- May 2020 — 6 yrs on file
- Year of graduation
- 2015 — 11 yrs since
- Specialty taxonomy
- 363LF0000X — NUCC code
- State license (1)
- New York #344075
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1336761352. Last verified May 11, 2026.Open Payments
Industry payments received
All-time total
$2,491
Transactions
83
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| ABBVIE INC. | 19 | $379.13 | |
| EMD Serono, Inc. | 6 | $211.80 | |
| Vanda Pharmaceuticals Inc. | 5 | $172.93 | |
| Genentech USA, Inc. | 12 | $167.47 | |
| Teva Pharmaceuticals USA, Inc. | 4 | $165.48 | |
| TG Therapeutics, Inc. | 8 | $144.88 | |
| Sumitomo Pharma America, Inc. | 7 | $136.17 | |
| Amgen Inc. | 1 | $135.32 | |
| E.R. Squibb & Sons, L.L.C. | 1 | $120.69 | |
| Genentech, Inc. | 1 | $106.12 | |
| SK Life Science, Inc. | 5 | $94.33 | |
| Biogen, Inc. | 4 | $80.57 | |
| Neurocrine Biosciences, Inc. | 4 | $71.60 | |
| Ipsen Biopharmaceuticals, Inc | 3 | $60.58 | |
| Mallinckrodt Hospital Products Inc. | 3 | $59.09 |
By nature of payment
Frequently asked questions
What is Dr. Emily Kennedy's medical specialty?
Dr. Emily Kennedy practices Family Nurse Practitioner in Staten Island, NY.
Where does Dr. Emily Kennedy practice?
Dr. Emily Kennedy practices at 16 Elmira Ave, Staten Island, NY 103142311. Office phone: 9175842103.
What is Dr. Emily Kennedy's NPI?
Dr. Emily Kennedy's National Provider Identifier (NPI) is 1336761352, issued by NPPES.
Does Dr. Emily Kennedy accept Medicare assignment?
Dr. Emily Kennedy does not accept Medicare assignment for all services. Patients may be billed amounts beyond Medicare-allowed charges.